Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC et al
Case Number:
1:12-cv-03846
Court:
Nature of Suit:
Judge:
Honorable Rebecca R. Pallmeyer
Firms
Companies
Sectors & Industries:
-
October 01, 2015
Mylan Infringed Cumberland's Acetadote Patent, Judge Rules
An Illinois federal judge held Wednesday that Mylan Institutional LLC infringed on Tennessee drugmaker Cumberland Pharmaceuticals Inc.'s patent for the overdose treatment drug Acetadote, holding that the U.S. Food and Drug Administration's formula for Acetadote was not a "definite and permanent" idea.
-
May 18, 2012
Cumberland Sues To Stop Mylan's Generic Acetadote
Tennessee drugmaker Cumberland Pharmaceuticals Inc. on Thursday launched a patent infringement suit in Illinois federal court challenging Mylan Institutional LLC's attempt to score U.S. approval of a generic version of the overdose treatment drug Acetadote.